Selected article for: "acute infection and respiratory tract disease"
Author: Sadeghmousavi, Shaghayegh; Rezaei, Nima
Title: COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
  • Cord-id: r56wvnup
  • Document date: 2020_9_3
    • ID: r56wvnup
    Snippet: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to Coronavirus disease 2019 (COVID-19), is not always confined to the respiratory tract, while patients with can develop neurological manifestations. The patients with multiple sclerosis (MS) pose challenges in this pandemic situation, because of the immunosuppressive medications they get and the fact that viral infections may contribute to MS exacerbation and relapses as an environmental factor in genetically p
    Document: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), leading to Coronavirus disease 2019 (COVID-19), is not always confined to the respiratory tract, while patients with can develop neurological manifestations. The patients with multiple sclerosis (MS) pose challenges in this pandemic situation, because of the immunosuppressive medications they get and the fact that viral infections may contribute to MS exacerbation and relapses as an environmental factor in genetically predisposed individuals. Herein, possible consequences of COVID-19 which may carry for the MS patients and the underlying mechanisms of its impact are discussed.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adaptive immune system innate: 1, 2, 3
    • acute ards respiratory distress syndrome and adaptive immune system innate response: 1
    • acute ards respiratory distress syndrome and additional risk: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and live vaccine: 1
    • acute ards respiratory distress syndrome and local failure: 1, 2
    • acute ards respiratory distress syndrome and long term immune memory: 1
    • acute ards respiratory distress syndrome and long term immune memory development: 1
    • acute ards respiratory distress syndrome and low exposure: 1, 2
    • acute respiratory failure and adaptive immune system: 1
    • acute respiratory failure and additional risk: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory failure and local failure: 1
    • acute respiratory failure and low exposure: 1, 2, 3, 4
    • adaptive immune system and low exposure: 1
    • adaptive immune system innate and low exposure: 1
    • additional risk and live vaccine: 1